Target Price | $35.73 |
Price | $9.58 |
Potential |
272.94%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target REGENXBIO, Inc. 2025 .
The average REGENXBIO, Inc. target price is $35.73.
This is
272.94%
register free of charge
$52.00
442.80%
register free of charge
$18.00
87.89%
register free of charge
|
|
A rating was issued by 11 analysts: 11 Analysts recommend REGENXBIO, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the REGENXBIO, Inc. stock has an average upside potential 2025 of
272.94%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 90.24 | 86.66 |
19.94% | 3.97% | |
EBITDA Margin | -277.94% | -261.21% |
25.33% | 6.02% | |
Net Margin | -330.42% | -270.35% |
15.69% | 18.18% |
10 Analysts have issued a sales forecast REGENXBIO, Inc. 2024 . The average REGENXBIO, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an REGENXBIO, Inc. EBITDA forecast 2024. The average REGENXBIO, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 REGENXBIO, Inc. Analysts have issued a net profit forecast 2024. The average REGENXBIO, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -6.02 | -4.73 |
7.38% | 21.43% | |
P/E | negative | |
EV/Sales | 4.21 |
3 Analysts have issued a REGENXBIO, Inc. forecast for earnings per share. The average REGENXBIO, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the REGENXBIO, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
REGENXBIO, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.